Report Cover

Global COVID-19 Molecular Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The COVID-19 Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global COVID-19 Molecular Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global COVID-19 Molecular Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
COVID-19 Molecular Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    High-throughput Sequencing
    Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
    Immunological Detection

Market segment by Application, can be divided into
    Hospitals
    Scientific Research
    Biodiagnostics

Market segment by players, this report covers
    Cellex
    Abbott
    Roche
    BioMedomics
    BD
    Henry Schein
    Safecare Bio-Tech
    Thermo Fisher
    Bio-rad
    Agilent
    Ortho Clinical Diagnostics
    Zhejiang Orient Gene Biotech
    Innovita Biological Technology
    Guangzhou Wondfo Biotech
    Guangdong Hecin-Scientific
    Dynamiker Biotechnology (Tianjin)
    ADVAITE
    Mayo Clinic Laboratories
    Chembio Diagnostics
    Mount Sinai Laboratory
    QIAGEN
    Bioer
    Biosynex
    Esco
    Analytik Jena
    Techne
    Da An Gene
    BGI
    Shanghai ZJ Bio-Tech

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of COVID-19 Molecular Diagnostics
    1.2 Classification of COVID-19 Molecular Diagnostics by Type
        1.2.1 Overview: Global COVID-19 Molecular Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Type in 2020
        1.2.3 High-throughput Sequencing
        1.2.4 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
        1.2.5 Immunological Detection
    1.3 Global COVID-19 Molecular Diagnostics Market by Application
        1.3.1 Overview: Global COVID-19 Molecular Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Scientific Research
        1.3.4 Biodiagnostics
    1.4 Global COVID-19 Molecular Diagnostics Market Size & Forecast
    1.5 Global COVID-19 Molecular Diagnostics Market Size and Forecast by Region
        1.5.1 Global COVID-19 Molecular Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global COVID-19 Molecular Diagnostics Market Size by Region, (2016-2021)
        1.5.3 North America COVID-19 Molecular Diagnostics Market Size and Prospect (2016-2026)
        1.5.4 Europe COVID-19 Molecular Diagnostics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific COVID-19 Molecular Diagnostics Market Size and Prospect (2016-2026)
        1.5.6 South America COVID-19 Molecular Diagnostics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa COVID-19 Molecular Diagnostics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 COVID-19 Molecular Diagnostics Market Drivers
        1.6.2 COVID-19 Molecular Diagnostics Market Restraints
        1.6.3 COVID-19 Molecular Diagnostics Trends Analysis
2 Company Profiles
    2.1 Cellex
        2.1.1 Cellex Details
        2.1.2 Cellex Major Business
        2.1.3 Cellex COVID-19 Molecular Diagnostics Product and Solutions
        2.1.4 Cellex COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Cellex Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott COVID-19 Molecular Diagnostics Product and Solutions
        2.2.4 Abbott COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Abbott Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche COVID-19 Molecular Diagnostics Product and Solutions
        2.3.4 Roche COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 BioMedomics
        2.4.1 BioMedomics Details
        2.4.2 BioMedomics Major Business
        2.4.3 BioMedomics COVID-19 Molecular Diagnostics Product and Solutions
        2.4.4 BioMedomics COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 BioMedomics Recent Developments and Future Plans
    2.5 BD
        2.5.1 BD Details
        2.5.2 BD Major Business
        2.5.3 BD COVID-19 Molecular Diagnostics Product and Solutions
        2.5.4 BD COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 BD Recent Developments and Future Plans
    2.6 Henry Schein
        2.6.1 Henry Schein Details
        2.6.2 Henry Schein Major Business
        2.6.3 Henry Schein COVID-19 Molecular Diagnostics Product and Solutions
        2.6.4 Henry Schein COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Henry Schein Recent Developments and Future Plans
    2.7 Safecare Bio-Tech
        2.7.1 Safecare Bio-Tech Details
        2.7.2 Safecare Bio-Tech Major Business
        2.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product and Solutions
        2.7.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Safecare Bio-Tech Recent Developments and Future Plans
    2.8 Thermo Fisher
        2.8.1 Thermo Fisher Details
        2.8.2 Thermo Fisher Major Business
        2.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Product and Solutions
        2.8.4 Thermo Fisher COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Thermo Fisher Recent Developments and Future Plans
    2.9 Bio-rad
        2.9.1 Bio-rad Details
        2.9.2 Bio-rad Major Business
        2.9.3 Bio-rad COVID-19 Molecular Diagnostics Product and Solutions
        2.9.4 Bio-rad COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Bio-rad Recent Developments and Future Plans
    2.10 Agilent 
        2.10.1 Agilent Details
        2.10.2 Agilent Major Business
        2.10.3 Agilent COVID-19 Molecular Diagnostics Product and Solutions
        2.10.4 Agilent COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Agilent Recent Developments and Future Plans
    2.11 Ortho Clinical Diagnostics
        2.11.1 Ortho Clinical Diagnostics Details
        2.11.2 Ortho Clinical Diagnostics Major Business
        2.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product and Solutions
        2.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
    2.12 Zhejiang Orient Gene Biotech
        2.12.1 Zhejiang Orient Gene Biotech Details
        2.12.2 Zhejiang Orient Gene Biotech Major Business
        2.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product and Solutions
        2.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Zhejiang Orient Gene Biotech Recent Developments and Future Plans
    2.13 Innovita Biological Technology
        2.13.1 Innovita Biological Technology Details
        2.13.2 Innovita Biological Technology Major Business
        2.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Product and Solutions
        2.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Innovita Biological Technology Recent Developments and Future Plans
    2.14 Guangzhou Wondfo Biotech
        2.14.1 Guangzhou Wondfo Biotech Details
        2.14.2 Guangzhou Wondfo Biotech Major Business
        2.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product and Solutions
        2.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Guangzhou Wondfo Biotech Recent Developments and Future Plans
    2.15 Guangdong Hecin-Scientific
        2.15.1 Guangdong Hecin-Scientific Details
        2.15.2 Guangdong Hecin-Scientific Major Business
        2.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product and Solutions
        2.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Guangdong Hecin-Scientific Recent Developments and Future Plans
    2.16 Dynamiker Biotechnology (Tianjin)
        2.16.1 Dynamiker Biotechnology (Tianjin) Details
        2.16.2 Dynamiker Biotechnology (Tianjin) Major Business
        2.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product and Solutions
        2.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans
    2.17 ADVAITE
        2.17.1 ADVAITE Details
        2.17.2 ADVAITE Major Business
        2.17.3 ADVAITE COVID-19 Molecular Diagnostics Product and Solutions
        2.17.4 ADVAITE COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 ADVAITE Recent Developments and Future Plans
    2.18 Mayo Clinic Laboratories
        2.18.1 Mayo Clinic Laboratories Details
        2.18.2 Mayo Clinic Laboratories Major Business
        2.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product and Solutions
        2.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 Mayo Clinic Laboratories Recent Developments and Future Plans
    2.19 Chembio Diagnostics
        2.19.1 Chembio Diagnostics Details
        2.19.2 Chembio Diagnostics Major Business
        2.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Product and Solutions
        2.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.19.5 Chembio Diagnostics Recent Developments and Future Plans
    2.20 Mount Sinai Laboratory
        2.20.1 Mount Sinai Laboratory Details
        2.20.2 Mount Sinai Laboratory Major Business
        2.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product and Solutions
        2.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.20.5 Mount Sinai Laboratory Recent Developments and Future Plans
    2.21 QIAGEN
        2.21.1 QIAGEN Details
        2.21.2 QIAGEN Major Business
        2.21.3 QIAGEN COVID-19 Molecular Diagnostics Product and Solutions
        2.21.4 QIAGEN COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.21.5 QIAGEN Recent Developments and Future Plans
    2.22 Bioer
        2.22.1 Bioer Details
        2.22.2 Bioer Major Business
        2.22.3 Bioer COVID-19 Molecular Diagnostics Product and Solutions
        2.22.4 Bioer COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.22.5 Bioer Recent Developments and Future Plans
    2.23 Biosynex
        2.23.1 Biosynex Details
        2.23.2 Biosynex Major Business
        2.23.3 Biosynex COVID-19 Molecular Diagnostics Product and Solutions
        2.23.4 Biosynex COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.23.5 Biosynex Recent Developments and Future Plans
    2.24 Esco
        2.24.1 Esco Details
        2.24.2 Esco Major Business
        2.24.3 Esco COVID-19 Molecular Diagnostics Product and Solutions
        2.24.4 Esco COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.24.5 Esco Recent Developments and Future Plans
    2.25 Analytik Jena
        2.25.1 Analytik Jena Details
        2.25.2 Analytik Jena Major Business
        2.25.3 Analytik Jena COVID-19 Molecular Diagnostics Product and Solutions
        2.25.4 Analytik Jena COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.25.5 Analytik Jena Recent Developments and Future Plans
    2.26 Techne
        2.26.1 Techne Details
        2.26.2 Techne Major Business
        2.26.3 Techne COVID-19 Molecular Diagnostics Product and Solutions
        2.26.4 Techne COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.26.5 Techne Recent Developments and Future Plans
    2.27 Da An Gene
        2.27.1 Da An Gene Details
        2.27.2 Da An Gene Major Business
        2.27.3 Da An Gene COVID-19 Molecular Diagnostics Product and Solutions
        2.27.4 Da An Gene COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.27.5 Da An Gene Recent Developments and Future Plans
    2.28 BGI
        2.28.1 BGI Details
        2.28.2 BGI Major Business
        2.28.3 BGI COVID-19 Molecular Diagnostics Product and Solutions
        2.28.4 BGI COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.28.5 BGI Recent Developments and Future Plans
    2.29 Shanghai ZJ Bio-Tech
        2.29.1 Shanghai ZJ Bio-Tech Details
        2.29.2 Shanghai ZJ Bio-Tech Major Business
        2.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product and Solutions
        2.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
        2.29.5 Shanghai ZJ Bio-Tech Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global COVID-19 Molecular Diagnostics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 COVID-19 Molecular Diagnostics Players Market Share
        3.2.2 Top 10 COVID-19 Molecular Diagnostics Players Market Share
        3.2.3 Market Competition Trend
    3.3 COVID-19 Molecular Diagnostics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global COVID-19 Molecular Diagnostics Revenue and Market Share by Type (2016-2021)
    4.2 Global COVID-19 Molecular Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2016-2021)
    5.2 COVID-19 Molecular Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America COVID-19 Molecular Diagnostics Revenue by Type (2016-2026)
    6.2 North America COVID-19 Molecular Diagnostics Revenue by Application (2016-2026)
    6.3 North America COVID-19 Molecular Diagnostics Market Size by Country
        6.3.1 North America COVID-19 Molecular Diagnostics Revenue by Country (2016-2026)
        6.3.2 United States COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        6.3.3 Canada COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        6.3.4 Mexico COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe COVID-19 Molecular Diagnostics Revenue by Type (2016-2026)
    7.2 Europe COVID-19 Molecular Diagnostics Revenue by Application (2016-2026)
    7.3 Europe COVID-19 Molecular Diagnostics Market Size by Country
        7.3.1 Europe COVID-19 Molecular Diagnostics Revenue by Country (2016-2026)
        7.3.2 Germany COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        7.3.3 France COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        7.3.5 Russia COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        7.3.6 Italy COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Type (2016-2026)
    8.2 Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Application (2016-2026)
    8.3 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region
        8.3.1 Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Region (2016-2026)
        8.3.2 China COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        8.3.3 Japan COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        8.3.4 South Korea COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        8.3.5 India COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        8.3.7 Australia COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America COVID-19 Molecular Diagnostics Revenue by Type (2016-2026)
    9.2 South America COVID-19 Molecular Diagnostics Revenue by Application (2016-2026)
    9.3 South America COVID-19 Molecular Diagnostics Market Size by Country
        9.3.1 South America COVID-19 Molecular Diagnostics Revenue by Country (2016-2026)
        9.3.2 Brazil COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        9.3.3 Argentina COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Type (2016-2026)
    10.2 Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Application (2016-2026)
    10.3 Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country
        10.3.1 Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Country (2016-2026)
        10.3.2 Turkey COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
        10.3.4 UAE COVID-19 Molecular Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global COVID-19 Molecular Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global COVID-19 Molecular Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market COVID-19 Molecular Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global COVID-19 Molecular Diagnostics Revenue (USD Million) by Region (2016-2021) Table 5. Global COVID-19 Molecular Diagnostics Revenue Market Share by Region (2021-2026) Table 6. Cellex Corporate Information, Head Office, and Major Competitors Table 7. Cellex Major Business Table 8. Cellex COVID-19 Molecular Diagnostics Product and Solutions Table 9. Cellex COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Abbott Corporate Information, Head Office, and Major Competitors Table 11. Abbott Major Business Table 12. Abbott COVID-19 Molecular Diagnostics Product and Solutions Table 13. Abbott COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Roche Corporate Information, Head Office, and Major Competitors Table 15. Roche Major Business Table 16. Roche COVID-19 Molecular Diagnostics Product and Solutions Table 17. Roche COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. BioMedomics Corporate Information, Head Office, and Major Competitors Table 19. BioMedomics Major Business Table 20. BioMedomics COVID-19 Molecular Diagnostics Product and Solutions Table 21. BioMedomics COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. BD Corporate Information, Head Office, and Major Competitors Table 23. BD Major Business Table 24. BD COVID-19 Molecular Diagnostics Product and Solutions Table 25. BD COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Henry Schein Corporate Information, Head Office, and Major Competitors Table 27. Henry Schein Major Business Table 28. Henry Schein COVID-19 Molecular Diagnostics Product and Solutions Table 29. Henry Schein COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Safecare Bio-Tech Corporate Information, Head Office, and Major Competitors Table 31. Safecare Bio-Tech Major Business Table 32. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product and Solutions Table 33. Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Thermo Fisher Corporate Information, Head Office, and Major Competitors Table 35. Thermo Fisher Major Business Table 36. Thermo Fisher COVID-19 Molecular Diagnostics Product and Solutions Table 37. Thermo Fisher COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Bio-rad Corporate Information, Head Office, and Major Competitors Table 39. Bio-rad Major Business Table 40. Bio-rad COVID-19 Molecular Diagnostics Product and Solutions Table 41. Bio-rad COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Agilent Corporate Information, Head Office, and Major Competitors Table 43. Agilent Major Business Table 44. Agilent COVID-19 Molecular Diagnostics Product and Solutions Table 45. Agilent COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors Table 47. Ortho Clinical Diagnostics Major Business Table 48. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product and Solutions Table 49. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Zhejiang Orient Gene Biotech Corporate Information, Head Office, and Major Competitors Table 51. Zhejiang Orient Gene Biotech Major Business Table 52. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product and Solutions Table 53. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Innovita Biological Technology Corporate Information, Head Office, and Major Competitors Table 55. Innovita Biological Technology Major Business Table 56. Innovita Biological Technology COVID-19 Molecular Diagnostics Product and Solutions Table 57. Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Guangzhou Wondfo Biotech Corporate Information, Head Office, and Major Competitors Table 59. Guangzhou Wondfo Biotech Major Business Table 60. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product and Solutions Table 61. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Guangdong Hecin-Scientific Corporate Information, Head Office, and Major Competitors Table 63. Guangdong Hecin-Scientific Major Business Table 64. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product and Solutions Table 65. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Dynamiker Biotechnology (Tianjin) Corporate Information, Head Office, and Major Competitors Table 67. Dynamiker Biotechnology (Tianjin) Major Business Table 68. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product and Solutions Table 69. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. ADVAITE Corporate Information, Head Office, and Major Competitors Table 71. ADVAITE Major Business Table 72. ADVAITE COVID-19 Molecular Diagnostics Product and Solutions Table 73. ADVAITE COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. Mayo Clinic Laboratories Corporate Information, Head Office, and Major Competitors Table 75. Mayo Clinic Laboratories Major Business Table 76. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product and Solutions Table 77. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 78. Chembio Diagnostics Corporate Information, Head Office, and Major Competitors Table 79. Chembio Diagnostics Major Business Table 80. Chembio Diagnostics COVID-19 Molecular Diagnostics Product and Solutions Table 81. Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 82. Mount Sinai Laboratory Corporate Information, Head Office, and Major Competitors Table 83. Mount Sinai Laboratory Major Business Table 84. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product and Solutions Table 85. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 86. QIAGEN Corporate Information, Head Office, and Major Competitors Table 87. QIAGEN Major Business Table 88. QIAGEN COVID-19 Molecular Diagnostics Product and Solutions Table 89. QIAGEN COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 90. Bioer Corporate Information, Head Office, and Major Competitors Table 91. Bioer Major Business Table 92. Bioer COVID-19 Molecular Diagnostics Product and Solutions Table 93. Bioer COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 94. Biosynex Corporate Information, Head Office, and Major Competitors Table 95. Biosynex Major Business Table 96. Biosynex COVID-19 Molecular Diagnostics Product and Solutions Table 97. Biosynex COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 98. Esco Corporate Information, Head Office, and Major Competitors Table 99. Esco Major Business Table 100. Esco COVID-19 Molecular Diagnostics Product and Solutions Table 101. Esco COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 102. Analytik Jena Corporate Information, Head Office, and Major Competitors Table 103. Analytik Jena Major Business Table 104. Analytik Jena COVID-19 Molecular Diagnostics Product and Solutions Table 105. Analytik Jena COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 106. Techne Corporate Information, Head Office, and Major Competitors Table 107. Techne Major Business Table 108. Techne COVID-19 Molecular Diagnostics Product and Solutions Table 109. Techne COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 110. Da An Gene Corporate Information, Head Office, and Major Competitors Table 111. Da An Gene Major Business Table 112. Da An Gene COVID-19 Molecular Diagnostics Product and Solutions Table 113. Da An Gene COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 114. BGI Corporate Information, Head Office, and Major Competitors Table 115. BGI Major Business Table 116. BGI COVID-19 Molecular Diagnostics Product and Solutions Table 117. BGI COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 118. Shanghai ZJ Bio-Tech Corporate Information, Head Office, and Major Competitors Table 119. Shanghai ZJ Bio-Tech Major Business Table 120. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product and Solutions Table 121. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 122. Global COVID-19 Molecular Diagnostics Revenue (USD Million) by Players (2019-2021) Table 123. Global COVID-19 Molecular Diagnostics Revenue Share by Players (2019-2021) Table 124. Breakdown of COVID-19 Molecular Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) Table 125. COVID-19 Molecular Diagnostics Players Head Office, Products and Services Provided Table 126. COVID-19 Molecular Diagnostics Mergers & Acquisitions in the Past Five Years Table 127. COVID-19 Molecular Diagnostics New Entrants and Expansion Plans Table 128. Global COVID-19 Molecular Diagnostics Revenue (USD Million) by Type (2016-2021) Table 129. Global COVID-19 Molecular Diagnostics Revenue Share by Type (2016-2021) Table 130. Global COVID-19 Molecular Diagnostics Revenue Forecast by Type (2021-2026) Table 131. Global COVID-19 Molecular Diagnostics Revenue by Application (2016-2021) Table 132. Global COVID-19 Molecular Diagnostics Revenue Forecast by Application (2021-2026) Table 133. North America COVID-19 Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million) Table 134. North America COVID-19 Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million) Table 135. North America COVID-19 Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million) Table 136. North America COVID-19 Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million) Table 137. North America COVID-19 Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million) Table 138. North America COVID-19 Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million) Table 139. Europe COVID-19 Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million) Table 140. Europe COVID-19 Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million) Table 141. Europe COVID-19 Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million) Table 142. Europe COVID-19 Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million) Table 143. Europe COVID-19 Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million) Table 144. Europe COVID-19 Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million) Table 145. Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million) Table 146. Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million) Table 147. Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million) Table 148. Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million) Table 149. Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Region (2016-2021) & (USD Million) Table 150. Asia-Pacific COVID-19 Molecular Diagnostics Revenue by Region (2021-2026) & (USD Million) Table 151. South America COVID-19 Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million) Table 152. South America COVID-19 Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million) Table 153. South America COVID-19 Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million) Table 154. South America COVID-19 Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million) Table 155. South America COVID-19 Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million) Table 156. South America COVID-19 Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million) Table 157. Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million) Table 158. Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million) Table 159. Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million) Table 160. Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million) Table 161. Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million) Table 162. Middle East & Africa COVID-19 Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. COVID-19 Molecular Diagnostics Picture Figure 2. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type in 2020 Figure 3. High-throughput Sequencing Figure 4. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Figure 5. Immunological Detection Figure 6. COVID-19 Molecular Diagnostics Revenue Market Share by Application in 2020 Figure 7. Hospitals Picture Figure 8. Scientific Research Picture Figure 9. Biodiagnostics Picture Figure 10. Global COVID-19 Molecular Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 11. Global COVID-19 Molecular Diagnostics Revenue and Forecast (2016-2026) & (USD Million) Figure 12. Global COVID-19 Molecular Diagnostics Revenue Market Share by Region (2016-2026) Figure 13. Global COVID-19 Molecular Diagnostics Revenue Market Share by Region in 2020 Figure 14. North America COVID-19 Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026) Figure 15. Europe COVID-19 Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. Asia-Pacific COVID-19 Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. South America COVID-19 Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. Middle East and Africa COVID-19 Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026) Figure 19. COVID-19 Molecular Diagnostics Market Drivers Figure 20. COVID-19 Molecular Diagnostics Market Restraints Figure 21. COVID-19 Molecular Diagnostics Market Trends Figure 22. Cellex Recent Developments and Future Plans Figure 23. Abbott Recent Developments and Future Plans Figure 24. Roche Recent Developments and Future Plans Figure 25. BioMedomics Recent Developments and Future Plans Figure 26. BD Recent Developments and Future Plans Figure 27. Henry Schein Recent Developments and Future Plans Figure 28. Safecare Bio-Tech Recent Developments and Future Plans Figure 29. Thermo Fisher Recent Developments and Future Plans Figure 30. Bio-rad Recent Developments and Future Plans Figure 31. Agilent Recent Developments and Future Plans Figure 32. Ortho Clinical Diagnostics Recent Developments and Future Plans Figure 33. Zhejiang Orient Gene Biotech Recent Developments and Future Plans Figure 34. Innovita Biological Technology Recent Developments and Future Plans Figure 35. Guangzhou Wondfo Biotech Recent Developments and Future Plans Figure 36. Guangdong Hecin-Scientific Recent Developments and Future Plans Figure 37. Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans Figure 38. ADVAITE Recent Developments and Future Plans Figure 39. Mayo Clinic Laboratories Recent Developments and Future Plans Figure 40. Chembio Diagnostics Recent Developments and Future Plans Figure 41. Mount Sinai Laboratory Recent Developments and Future Plans Figure 42. QIAGEN Recent Developments and Future Plans Figure 43. Bioer Recent Developments and Future Plans Figure 44. Biosynex Recent Developments and Future Plans Figure 45. Esco Recent Developments and Future Plans Figure 46. Analytik Jena Recent Developments and Future Plans Figure 47. Techne Recent Developments and Future Plans Figure 48. Da An Gene Recent Developments and Future Plans Figure 49. BGI Recent Developments and Future Plans Figure 50. Shanghai ZJ Bio-Tech Recent Developments and Future Plans Figure 51. Global COVID-19 Molecular Diagnostics Revenue Share by Players in 2020 Figure 52. COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 53. Global Top 3 Players COVID-19 Molecular Diagnostics Revenue Market Share in 2020 Figure 54. Global Top 10 Players COVID-19 Molecular Diagnostics Revenue Market Share in 2020 Figure 55. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 56. Global COVID-19 Molecular Diagnostics Revenue Share by Type in 2020 Figure 57. Global COVID-19 Molecular Diagnostics Market Share Forecast by Type (2021-2026) Figure 58. Global COVID-19 Molecular Diagnostics Revenue Share by Application in 2020 Figure 59. Global COVID-19 Molecular Diagnostics Market Share Forecast by Application (2021-2026) Figure 60. North America COVID-19 Molecular Diagnostics Sales Market Share by Type (2016-2026) Figure 61. North America COVID-19 Molecular Diagnostics Sales Market Share by Application (2016-2026) Figure 62. North America COVID-19 Molecular Diagnostics Revenue Market Share by Country (2016-2026) Figure 63. United States COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. Canada COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Mexico COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Europe COVID-19 Molecular Diagnostics Sales Market Share by Type (2016-2026) Figure 67. Europe COVID-19 Molecular Diagnostics Sales Market Share by Application (2016-2026) Figure 68. Europe COVID-19 Molecular Diagnostics Revenue Market Share by Country (2016-2026) Figure 69. Germany COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. France COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. United Kingdom COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Russia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. Italy COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Asia-Pacific COVID-19 Molecular Diagnostics Sales Market Share by Type (2016-2026) Figure 75. Asia-Pacific COVID-19 Molecular Diagnostics Sales Market Share by Application (2016-2026) Figure 76. Asia-Pacific COVID-19 Molecular Diagnostics Revenue Market Share by Region (2016-2026) Figure 77. China COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Japan COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. South Korea COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. India COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 81. Southeast Asia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 82. Australia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 83. South America COVID-19 Molecular Diagnostics Sales Market Share by Type (2016-2026) Figure 84. South America COVID-19 Molecular Diagnostics Sales Market Share by Application (2016-2026) Figure 85. South America COVID-19 Molecular Diagnostics Revenue Market Share by Country (2016-2026) Figure 86. Brazil COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 87. Argentina COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 88. Middle East and Africa COVID-19 Molecular Diagnostics Sales Market Share by Type (2016-2026) Figure 89. Middle East and Africa COVID-19 Molecular Diagnostics Sales Market Share by Application (2016-2026) Figure 90. Middle East and Africa COVID-19 Molecular Diagnostics Revenue Market Share by Country (2016-2026) Figure 91. Turkey COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 92. Saudi Arabia COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 93. UAE COVID-19 Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 94. Methodology Figure 95. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us